Taysha Gene Therapies, Inc.
TSHA
$4.06
-$0.37-8.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 297.34M | 312.76M | 116.59M | 139.04M | 157.69M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 806.00K | 495.00K | 2.06M | 1.36M | 1.87M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.80M | 3.01M | 2.05M | 1.73M | 2.00M |
| Total Current Assets | 299.95M | 316.26M | 120.71M | 142.13M | 161.56M |
|
|
|||||
| Total Current Assets | 299.95M | 316.26M | 120.71M | 142.13M | 161.56M |
| Net Property, Plant & Equipment | 14.27M | 14.73M | 15.32M | 15.87M | 16.29M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.34M | 2.34M | 2.34M | 2.37M | 2.37M |
| Total Assets | 316.55M | 333.33M | 138.36M | 160.36M | 180.22M |
|
|
|||||
| Total Accounts Payable | 5.44M | 7.71M | 4.33M | 3.59M | 4.93M |
| Total Accrued Expenses | 14.39M | 9.00M | 7.81M | 9.59M | 9.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.67M | 1.74M | 1.81M | 1.88M | 1.82M |
| Total Finance Division Other Current Liabilities | 7.14M | 6.89M | 8.61M | 11.17M | 13.19M |
| Total Other Current Liabilities | 7.14M | 6.89M | 8.61M | 11.17M | 13.19M |
| Total Current Liabilities | 28.63M | 25.35M | 22.56M | 26.23M | 29.34M |
|
|
|||||
| Total Current Liabilities | 28.63M | 25.35M | 22.56M | 26.23M | 29.34M |
| Long-Term Debt | 50.85M | 41.05M | 42.45M | 43.94M | 42.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.56M | 16.98M | 17.37M | 17.74M | 18.23M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.52M | 1.23M | 925.00K | 930.00K | 882.00K |
| Total Liabilities | 97.57M | 84.60M | 83.30M | 88.84M | 91.42M |
|
|
|||||
| Common Stock & APIC | 903.58M | 900.14M | 681.18M | 677.86M | 674.65M |
| Retained Earnings | -683.45M | -650.72M | -623.83M | -602.31M | -583.52M |
| Treasury Stock & Other | -1.14M | -699.00K | -2.29M | -4.03M | -2.33M |
| Total Common Equity | 218.99M | 248.73M | 55.06M | 71.53M | 88.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 218.99M | 248.73M | 55.06M | 71.53M | 88.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 218.99M | 248.73M | 55.06M | 71.53M | 88.80M |
|
|
|||||